The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Affirm Holdings, Inc. | Common-Class A | 00827B106 | 374,565 | 17,610 | SH | OTR | 17,610 | 0 | 0 | |||
Braze, Inc. | Common-Class A | 10576N102 | 289,352 | 6,192 | SH | OTR | 6,192 | 0 | 0 | |||
Corvus Pharmaceuticals, Inc. | Common | 221015100 | 4,782,399 | 3,275,616 | SH | SOLE | 3,275,616 | 0 | 0 | |||
Freshworks Inc. | Common- Class A | 358054104 | 1,212,371 | 60,862 | SH | OTR | 60,862 | 0 | 0 | |||
Fusion Pharmaceuticals, Inc. | Common | 36118A100 | 7,664,303 | 2,947,809 | SH | SOLE | 2,947,809 | 0 | 0 | |||
Icosavax, Inc. | Common | 45114M109 | 16,894,721 | 2,179,964 | SH | SOLE | 2,179,964 | 0 | 0 | |||
Mineralys Therapeutics, Inc. | Common | 603170101 | 21,895,149 | 2,302,329 | SH | SOLE | 2,302,329 | 0 | 0 | |||
Paylocity Holding Corporation | Common | 70438V106 | 103,280,460 | 568,412 | SH | SOLE | 568,412 | 0 | 0 | |||
PDD Holdings, Inc. | ADS | 722304102 | 29,239,571 | 298,150 | SH | OTR | 298,150 | 0 | 0 | |||
Q2 Holdings, Inc. | Common | 74736L109 | 25,091,926 | 777,562 | SH | SOLE | 777,562 | 0 | 0 | |||
Rimini Street, Inc. | Common | 76674Q107 | 51,843,953 | 23,565,433 | SH | SOLE | 23,565,433 | 0 | 0 | |||
Sprinklr, Inc. | Common-Class A | 85208T107 | 2,961,926 | 214,012 | SH | OTR | 214,012 | 0 | 0 | |||
UiPath, Inc. | Common- Class A | 90364P105 | 1,949,753 | 113,954 | SH | OTR | 113,954 | 0 | 0 | |||
Vacasa, Inc. | Common- Class A | 91854V107 | 18,764,501 | 8,631,670 | SH | SOLE | 8,631,670 | 0 | 0 |